Corcept Therapeutics presents data from MOMENTUM trial in hypercortisolism at American College of Cardiology Annual Scientific Session
Corcept Therapeutics presented late-breaking data from its MOMENTUM trial examining the prevalence of endogenous hypercortisolism in patients with resistant hypertension at the 2026 American College of Cardiology Annual… read more.
